Conversio Health Delivers Improved Patient Outcomes and Reduced Costs with Groundbreaking COPD and Asthma Disease Management Program
SAN LUIS OBISPO, Calif., Feb. 8, 2024 /PRNewswire-PRWeb/ -- Conversio Health, the leading innovator in respiratory disease care, today announced the success of its pioneering COPD and Asthma disease management program—significantly improving patient outcomes and reducing costs for patients and healthcare stakeholders. Their program has grown rapidly over the past 18 months, consistently partnering with new provider groups and health plans. The Conversio Health chronic respiratory management program delivers the most comprehensive patient care solution:
- New website for Conversio's disease management program highlights significant improvements in patient care and cost associated with chronic respiratory conditions.
- SAN LUIS OBISPO, Calif., Feb. 8, 2024 /PRNewswire-PRWeb/ -- Conversio Health, the leading innovator in respiratory disease care, today announced the success of its pioneering COPD and Asthma disease management program—significantly improving patient outcomes and reducing costs for patients and healthcare stakeholders.
- Their program has grown rapidly over the past 18 months, consistently partnering with new provider groups and health plans.
- The Conversio Health chronic respiratory management program delivers the most comprehensive patient care solution:
Custom Nebulizer Medications: Improve drug delivery & lung penetration and provide cost savings to patients & health plans.